Page last updated: 2024-09-05

sb 203580 and valine

sb 203580 has been researched along with valine in 4 studies

Compound Research Comparison

Studies
(sb 203580)
Trials
(sb 203580)
Recent Studies (post-2010)
(sb 203580)
Studies
(valine)
Trials
(valine)
Recent Studies (post-2010) (valine)
3,48941,13715,4651,1763,932

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fujita, T; Goto, A; Hirata, Y; Nagai, R; Nishimatsu, H; Oba, S; Omata, M; Satonaka, H; Suzuki, E; Takeda, R1
Akiyoshi, Y; Miyamoto, S; Morishima, M; Ono, K; Wang, Y1
O'Connor, JJ; Pickering, M; Watters, O1
Greig, NH; Mukandala, G; O'Connor, JJ; Wall, AM1

Other Studies

4 other study(ies) available for sb 203580 and valine

ArticleYear
Calcineurin promotes the expression of monocyte chemoattractant protein-1 in vascular myocytes and mediates vascular inflammation.
    Circulation research, 2004, Mar-19, Volume: 94, Issue:5

    Topics: Angiotensin II; Animals; Calcineurin; Calcium Signaling; Calcium-Calmodulin-Dependent Protein Kinases; Cardiomyopathy, Hypertrophic; Cells, Cultured; Chemokine CCL2; Cyclosporine; Femoral Artery; Gene Expression Regulation; Humans; Hyperplasia; Imidazoles; Macrophages; MAP Kinase Kinase 6; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Promoter Regions, Genetic; Protein Biosynthesis; Proteins; Pyridines; Rats; Recombinant Fusion Proteins; RNA, Messenger; Signal Transduction; Tetrazoles; Transcription, Genetic; Tunica Intima; Valine; Valsartan; Vasculitis

2004
Telmisartan, an angiotensin II type 1 receptor antagonist, attenuates T-type Ca2+ channel expression in neonatal rat cardiomyocytes.
    European journal of pharmacology, 2009, May-01, Volume: 609, Issue:1-3

    Topics: Action Potentials; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Newborn; Benzimidazoles; Benzoates; Calcium Channels, T-Type; Cells, Cultured; Dose-Response Relationship, Drug; Drug Interactions; Electrophysiology; Extracellular Signal-Regulated MAP Kinases; F-Box Proteins; Flavonoids; Gene Expression Regulation; Heart Rate; Imidazoles; JNK Mitogen-Activated Protein Kinases; Membrane Potentials; Myocytes, Cardiac; p38 Mitogen-Activated Protein Kinases; Patch-Clamp Techniques; Pyridines; Rats; Rats, Wistar; RNA, Messenger; Telmisartan; Tetrazoles; Time Factors; Valine; Valsartan; Zebrafish Proteins

2009
Preconditioning effects of tumor necrosis factor-α and glutamate on calcium dynamics in rat organotypic hippocampal cultures.
    Journal of neuroimmunology, 2011, Volume: 234, Issue:1-2

    Topics: Animals; Animals, Newborn; Calcium; Cell Death; Cell Survival; Drug Administration Schedule; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Female; Glutamic Acid; Hippocampus; Imidazoles; Male; Nonlinear Dynamics; Organ Culture Techniques; Propidium; Pyridines; Rats; Rats, Wistar; Signal Transduction; Time Factors; Tumor Necrosis Factor-alpha; Valine

2011
Tumor necrosis factor-α potentiates long-term potentiation in the rat dentate gyrus after acute hypoxia.
    Journal of neuroscience research, 2015, Volume: 93, Issue:5

    Topics: Animals; Animals, Newborn; Anti-Inflammatory Agents, Non-Steroidal; Cells, Cultured; Dentate Gyrus; Electric Stimulation; Excitatory Postsynaptic Potentials; Hypoxia; Imidazoles; In Vitro Techniques; Interleukin-1beta; L-Lactate Dehydrogenase; Lipopolysaccharides; Long-Term Potentiation; Male; Patch-Clamp Techniques; Pyridines; Rats; Tumor Necrosis Factor-alpha; Valine

2015